| Literature DB >> 36259050 |
Martha Ofelia Correa Posada1,2, Laura Maria Contreras Correa2,3, John Fernando García Vélez1.
Abstract
Background: Varicose veins are a highly prevalent condition in the general population, generating variable reasons for consultation that can alter the patient's quality of life, with prevalence and associated factors that vary in different series.Entities:
Keywords: epidemiology; risk factors; varicose veins
Year: 2022 PMID: 36259050 PMCID: PMC9565676 DOI: 10.1590/1677-5449.202200513
Source DB: PubMed Journal: J Vasc Bras ISSN: 1677-5449
Variables associated with varicose veins according to gender.
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| 0.045 | |||||
| 15-35 | 76 | 8.3 | 31 | 13.8 | 107 (9.4) | |
| 36-50 | 275 | 30.2 | 71 | 31.6 | 346 (30.5) | |
| 51-60 | 282 | 31.0 | 68 | 30.2 | 350 (30.8) | |
| > 60 | 278 | 30.5 | 55 | 24.4 | 333 (29.3) | |
|
| 0.000 | |||||
| 0 | ||||||
| 1 | 7 | 0.8 | 6 | 2.7 | 13 (1.1) | |
| 2 | 217 | 23.8 | 15 | 6.7 | 232 (20.4) | |
| 3 | 429 | 47.1 | 108 | 48.0 | 537 (47.3) | |
| 4 | 161 | 17.6 | 38 | 16.9 | 199 (17.5) | |
| 5 | 38 | 4.2 | 26 | 11.6 | 64 (5.6) | |
| 6 | 39 | 4.3 | 22 | 9.8 | 61 (5.5) | |
| 20 | 2.2 | 10 | 4.4 | 30 (2.6) | ||
|
| ||||||
| Edema | 433 | 47.5 | 94 | 41.8 | 527 (46.4) | 0.121 |
| Heaviness | 419 | 46.0 | 86 | 38.2 | 505 (44.5) | 0.36 |
| Tiredness | 563 | 61.8 | 125 | 55.6 | 688 (60.6) | 0.086 |
| Burning sensation | 514 | 56.4 | 83 | 36.9 | 597 (52.6) | 0.000 |
| Itching | 367 | 40.3 | 80 | 35.6 | 447 (39.3) | 0.193 |
| Pain | 598 | 65.6 | 123 | 54.7 | 721 (63.5) | 0.002 |
| Cramps | 402 | 44.1 | 86 | 38.2 | 488 (43.0) | 0.196 |
|
| 0.103 | |||||
| Underweight (< 18.5) | 6 | 0.7 | 4 | 1.8 | 10 (0.9) | |
| Normal weight (18.5–24.99) | 322 | 35.3 | 77 | 34.2 | 399 (35.1) | |
| Overweight (25–29.99) | 347 | 38.1 | 98 | 43.6 | 445 (39.2) | |
| Obesity (>30) | 236 | 26.0 | 46 | 20.4 | 282 (24.8) | |
|
| ||||||
| Diabetes | 56 | 6.1 | 10 | 4.4 | 66 (5.8) | 0.328 |
| Hypothyroidism | 166 | 18.2 | 8 | 3.6 | 174 (15.3) | 0.000 |
| Smoking | 72 | 8.0 | 30 | 13.3 | 102 (9.0) | 0.011 |
| Constipation | 134 | 14.7 | 10 | 4.4 | 144 (12.7) | 0.000 |
CEAP = clinical-etiological-anatomical-pathophysiological; BMI = body mass index.
Distribution of symptoms and nutritional status according to age group.
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
| |||||
| Edema | 39 (4.3%) | 131 (14.4%) | 136 (14.6%) | 127 (13.9%) | 0.832 |
| Heaviness | 43 (4.7%) | 137 (15.0%) | 118 (13.0%) | 121 (13.3%) | 0.053 |
| Tiredness | 61 (6.7%) | 174 (19.1%) | 166 (18.2%) | 162 (17.8%) | 0.003 |
| Burning sensation | 44 (4.8%) | 156 (17.1%) | 162 (17.8%) | 152 (16.7%) | 0.909 |
| Itching | 36 (4.0%) | 116 (12.7%) | 110 (12.2%) | 105 (11.5%) | 0.404 |
| Pain | 53 (5.8%) | 176 (19.3%) | 188 (20.6%) | 181(19.9%) | 0.787 |
| Cramps | 38 (4.2%) | 124 (13.6%) | 120 (13.2%) | 120 (13.2%) | 0.67 |
|
| |||||
| Edema | 14 (6.2%) | 32 (14.2) | 26 (11.6%) | 22 (9.8%) | 0.829 |
| Heaviness | 15 (6.7%) | 33 (14.7%) | 22 (9.8%) | 16 (87.1%) | 0.096 |
| Tiredness | 23 (10.2%) | 45 (20.0%) | 34 (15.1%) | 23 (10.2%) | 0.011 |
| Burning sensation | 15 (6.7%) | 26 (11.6%) | 24 (10.7%) | 18 (8.0%) | 0.523 |
| Itching | 16 (7.1%) | 26 (11.6%) | 21 (9.3%) | 17 (7.6%) | 0.196 |
| Pain | 17 (7.6%) | 41 (18.2%) | 33 (14.7%) | 32 (14.2%) | 0.664 |
| Cramps | 12 (5.3%) | 28 (12.4%) | 25 (11.1%) | 21 (9.3%) | 0.991 |
|
| 0.001 | ||||
| Underweight (< 18.5 kg/m2) | 0 (0.0%) | 0 (0.0%) | 2 (0.2%) | 4 (0.4%) | |
| Normal weight (18.5-24,9 kg/m2) | 44 (4.8%) | 106 (11.6%) | 86 (9.4%) | 86 (9.4%) | |
| Overweight (25-29,9 kg/m2) | 18 (2.0%) | 108 (11.9%) | 113 (12.4%) | 108 (11.9%) | |
| Obesity (> 30 kg/m2) | 14 (1.5%) | 61 (6.7%) | 81 (8.9%) | 80 (8.8%) | |
|
| 0.072 | ||||
| Underweight (< 18.5 kg/m2) | 3 (1.3%) | 0 (0.0%) | 1 (0.4%) | 0 (0.0%) | |
| Normal weight (18.5-24,9 kg/m2) | 11 (4.9%) | 24 (10.7%) | 21 (9.3%) | 21 (9.3%) | |
| Overweight (25-29,9 kg/m2) | 12 (5.3%) | 29 (12.9%) | 32 (14.2%) | 25 (11.1%) | |
| Obesity (> 30 kg/m2) | 5 (2.2%) | 18 (8.0%) | 14 (6.2%) | 9 (4.0%) | |
Distribution of age and symptoms according to CEAP clinical classification.
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| 0.000 | |||||||
| 15-35 | 2 (1.9%) | 14(13.1%) | 65 (60.7%) | 15 (14.0%) | 5 (4.7%) | 2 (1.9%) | 4 (3.7%) | |
| 36-50 | 4 (1.2%) | 76 (22.0%) | 164(47.4%) | 72 (20.8%) | 12 (3.5%) | 11 (3.2%) | 7 (2.0%) | |
| 51-60 | 6 (1.7%) | 75(21.4%) | 163(43.9%) | 64 (18.3%) | 17 (4.9%) | 16 (4.6%) | 9 (2.6%) | |
| > 60 | 1 (0.3%) | 67(20.1%) | 145 (43.5%) | 48 (14.4%) | 30 (9.0%) | 32 (9.6%) | 10 (3.0%) | |
|
| ||||||||
| Edema | 4 (0.8%) | 82(15.6%) | 213 (40.4%) | 140 (26.6%) | 35 (6.5%) | 19 (3.6%) | 1 (3.6%) | 0.000 |
| Heaviness | 7 (1.4%) | 101 (20.0%) | 231 (45.7%) | 99 (19.6%) | 24 (4.8%) | 26 (5.1%) | 17 (3.4%) | 0.380 |
| Tiredness | 8 (1.2%) | 131 (19.0%) | 339 (49.3%) | 126 (18.3%) | 32 (4.7%) | 33 (4.8%) | 19 (2.8%) | 0.245 |
| Burning sensation | 7 (1.2%) | 121(20.3%) | 289 (48.4%) | (17.9.6%) | 28 (4.7%) | 21 (3.5%) | 24 (4.0%) | 0.003 |
| Itching | 3 (3.7%) | 81 (18.1%) | 206 (46.1%) | 84 (18.8%) | 32 (7.2%) | 29 (6.5%) | 12 (2.7%) | 0.172 |
| Pain | 8 (1.1%) | 137 (19.0%) | 341(47.3%) | 135 (18.7%) | 42 (5.8%) | 31 (4.3%) | 27 (3.7%) | 0.009 |
| Cramps | 0 (0.0) | 102(20.9%) | 237(48.6%) | 92 (18.9%) | 21 (4.3%) | 20 (4.1%) | 16 (3.3%) | 0.007 |
CEAP = clinical-etiological-anatomical-pathophysiological.
Variables asociadas a las várices según el género.
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| 0,045 | |||||
| 15-35 | 76 | 8,3 | 31 | 13,8 | 107 (9,4) | |
| 36-50 | 275 | 30,2 | 71 | 31,6 | 346 (30,5) | |
| 51-60 | 282 | 31,0 | 68 | 30,2 | 350 (30,8) | |
| >60 | 278 | 30,5 | 55 | 24,4 | 333 (29,3) | |
|
| 0,000 | |||||
| 0 | 7 | 0,8 | 6 | 2,7 | 13 (1,1) | |
| 1 | 217 | 23,8 | 15 | 6,7 | 232 (20,4) | |
| 2 | 429 | 47,1 | 108 | 48 | 537 (47,3) | |
| 3 | 161 | 17,6 | 38 | 16,9 | 199 (17,5) | |
| 4 | 38 | 4,2 | 26 | 11,6 | 64 (5,6) | |
| 5 | 39 | 4,3 | 22 | 9.8 | 61 (5,5) | |
| 6 | 20 | 2,2 | 10 | 4,4 | 30 (2,6) | |
|
| ||||||
| Edema | 433 | 47,5 | 94 | 41,8 | 527 (46,4) | 0,121 |
| Pesadez | 419 | 46 | 86 | 38,2 | 505 (44,5) | 0,36 |
| Cansancio | 563 | 61,8 | 125 | 55,6 | 688 (60,6) | 0,086 |
| Ardor | 514 | 56,4 | 83 | 36,9 | 597 (52,6) | 0,000 |
| Prurito | 367 | 40,3 | 80 | 35,6 | 447 (39,3) | 0,193 |
| Dolor | 598 | 65,6 | 123 | 54,7 | 721 (63,5) | 0,002 |
| Calambres | 402 | 44,1 | 86 | 38,2 | 488 (43) | 0,196 |
|
| 0,103 | |||||
| Bajo peso (< 18,5) | 6 | 0,7 | 4 | 1,8 | 10 (0,9) | |
| Normal (18,5-24,99) | 322 | 35,3 | 77 | 34,2 | 399 (35,1) | |
| Sobrepeso (25-29,99) | 347 | 38,1 | 98 | 43,6 | 445 (39,2) | |
| Obesidad (> 30) | 236 | 26 | 46 | 20,4 | 282 (24,8) | |
|
| ||||||
| Diabetes | 56 | 6,1 | 10 | 4,4 | 66 (5,8) | 0,328 |
| Hipotiroidismo | 166 | 18,2 | 8 | 3,6 | 174 (15,3) | 0,000 |
| Fumador | 72 | 8 | 30 | 13,3 | 102 (9) | 0,011 |
| Constipación | 134 | 14,7 | 10 | 4,4 | 144 (12,7) | 0,000 |
CEAP = clinical, etiological, anatomical, pathophysiological; IMC = índice de masa corporal.
Distribución de los síntomas y estado nutricional según los grupos de edad.
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
| |||||
| Edema | 39 (4,3%) | 131 (14,4%) | 136 (14,6%) | 127 (13,9%) | 0,832 |
| Pesadez | 43 (4,7%) | 137 (15,0%) | 118 (13,0%) | 121 (13,3%) | 0,053 |
| Cansancio | 61 (6,7%) | 174 (19,1%) | 166 (18,2%) | 162 (17,8%) | 0,003 |
| Ardor | 44 (4,8%) | 156 (17,1%) | 162 (17,8%) | 152 (16,7%) | 0,909 |
| Prurito | 36 (4,0%) | 116 (12,7%) | 110 (12,2%) | 105 (11,5%) | 0,404 |
| Dolor | 53 (5,8%) | 176 (19,3%) | 188 (20,6%) | 181(19,9%) | 0,787 |
| Calambres | 38 (4,2%) | 124 (13,6%) | 120 (13,2%) | 120 (13,2%) | 0,670 |
|
| |||||
| Edema | 14 (6,2%) | 32 (14,2) | 26 (11,6%) | 22 (9,8%) | 0,829 |
| Pesadez | 15 (6,7%) | 33 (14,7%) | 22 (9,8%) | 16 (87,1%) | 0,096 |
| Cansancio | 23 (10,2%) | 45 (20,0%) | 34 (15,1%) | 23 (10,2%) | 0,011 |
| Ardor | 15 (6,7%) | 26 (11,6%) | 24 (10,7%) | 18 (8,0%) | 0,523 |
| Prurito | 16 (7,1%) | 26 (11,6%) | 21 (9,3%) | 17 (7,6%) | 0,196 |
| Dolor | 17 (7,6%) | 41 (18,2%) | 33 (14,7%) | 32 (14,2%) | 0,664 |
| Calambres | 12 (5,3%) | 28 (12,4%) | 25 (11,1%) | 21 (9,3%) | 0,991 |
|
| 0,001 | ||||
| Bajo peso (< 18,5 kg/m2) | 0 (0,0%) | 0 (0,0%) | 2 (0,2%) | 4 (0,4%) | |
| Normal (18,5-24,9 kg/m2) | 44 (4,8%) | 106 (11,6%) | 86 (9,4%) | 86 (9,4%) | |
| Sobrepeso (25-29,9 kg/m2) | 18 (2,0%) | 108 (11,9%) | 113 (12,4%) | 108 (11,9%) | |
| Obesidad (> 30 kg/m2) | 14 (1,5%) | 61 (6,7%) | 81 (8,9%) | 80 (8,8%) | |
|
| 0,072 | ||||
| Bajo peso (< 18,5 kg/m2) | 3 (1,3%) | 0 (0,0%) | 1 (0,4%) | 0 (0,0%) | |
| Normal (18,5-24,9 kg/m2) | 11 (4,9%) | 24 (10,7%) | 21 (9,3%) | 21 (9,3%) | |
| Sobrepeso (25-29,9 kg/m2) | 12 (5,3%) | 29 (12,9%) | 32 (14,2%) | 25 (11,1%) | |
| Obesidad (>30 kg/m2) | 5 (2,2%) | 18 (8,0%) | 14 (6,2%) | 9 (4,0%) | |
Distribución de la edad y síntomas según la clasificación clínica del CEAP.
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| Edad (años) | 0,000 | |||||||
| 15-35 | 2 (1,9%) | 14 (13,1%) | 65 (60,7%) | 15 (14%) | 5 (4,7%) | 2 (1,9%) | 4 (3,7%) | |
| 36-50 | 4 (1,2%) | 76 (22%) | 164 (47,4%) | 72 (20,8%) | 12 (3,5%) | 11 (3,2%) | 7 (2,0%) | |
| 51-60 | 6 (1,7%) | 75 (21,4%) | 163 (43,9%) | 64 (18,3%) | 17 (4,9%) | 16 (4,6%) | 9 (2,6%) | |
| > 60 | 1 (0,3%) | 67 (20,1%) | 145 (43,5%) | 48 (14,4%) | 30 (9,0%) | 32 (9,6%) | 10 (3.0%) | |
|
| ||||||||
| Edema | 4 (0,8%) | 82 (15,6%) | 213 (40,4%) | 140 (26,6%) | 35 (6,5%) | 19 (3,6%) | 1 (3,6%) | 0,000 |
| Pesadez | 7 (1,4%) | 101 (20,0%) | 231 (45,7%) | 99 (19,6%) | 24 (4,8%) | 26 (5,1%) | 17 (3,4%) | 0,380 |
| Cansancio | 8 (1,2%) | 131 (19,0%) | 339 (49,3%) | 126 (18,3%) | 32 (4,7%) | 33 (4,8%) | 19 (2,8%) | 0,245 |
| Ardor | 7 (1,2%) | 121 (20,3%) | 289 (48,4%) | 17,9 (4,6%) | 28 (4,7%) | 21 (3,5%) | 24 (4,0%) | 0,003 |
| Prurito | 3 (3,7%) | 81 (18,1%) | 206 (46,1%) | 84 (18,8%) | 32 (7,2%) | 29 (6,5%) | 12 (2,7%) | 0,172 |
| Dolor | 8 (1,1%) | 137 (19,0%) | 341 (47,3%) | 135 (18,7%) | 42 (5,8%) | 31 (4,3%) | 27 (3,7%) | 0,009 |
| Calambres | 0 (0,0%) | 102 (20,9%) | 237 (48,6%) | 92 (18,9%) | 21 (4,3%) | 20 (4,1%) | 16 (3,3%) | 0,007 |
CEAP = clinical, etiological, anatomical, pathophysiological.